Abbott Laboratories Launches ICRAS Tool to Help Do...
Category : Clinical Trial Update 13 March 2026Managing diabetes is not only about controlling blood sugar. For millions of patients, the real dang...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
ImmunoBrain to Present Phase 1b Data for Alzheimer...
Category : Clinical Trial Update 13 March 2026New approaches to treating neurodegenerative diseases are increasingly focusing on the role of the i...
Inimmune Corporation Advances Phase 2 Trial for IN...
Category : Clinical Trial Update 13 March 2026New treatment strategies for allergic diseases are increasingly focusing on modifying the immune sys...
Lundbeck Completes Patient Randomization in Phase...
Category : Clinical Trial Update 12 March 2026A major milestone has been reached in the search for treatments for Multiple System Atrophy (MSA)....
Gesynta Pharma Begins Phase 2 Trial of Vipoglansta...
Category : Clinical Trial Update 12 March 2026Gesynta Pharma AB has announced that the first patient has been dosed in its Phase 2 clinical trial...
Latest Newsletter Post
-
Inimmune Corporation Advances Phase..
13 March 2026
-
ImmunoBrain to Present Phase 1b Dat..
13 March 2026
-
Abbott Laboratories Launches ICRAS..
13 March 2026
-
Gesynta Pharma Begins Phase 2 Trial..
12 March 2026
-
Lundbeck Completes Patient Randomiz..
12 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com